Nation-wide multicenter registry for Myocardial Damage associated with immune checkpoint inhibitor administration

Nation-wide multicenter registry for Myocardial Damage associated with immune checkpoint inhibitor administration - MD-ICI

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042923

Enrollment

300

Registered

2021-01-10

Start date

2020-08-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Damage associated with immune checkpoint inhibitor administration

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who develop myocardial damage after ICI treatment

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

Measure	Time frame
Incident rate, onset time, and risk factors	—

Countries

Japan

Contacts

Public Contactasuka furukawa

International University of Health and Welfare, Mita Hospital Cardiovascular internal medicine

asukaf0326@gmail.com0334518121

Outcome results